63 related articles for article (PubMed ID: 7795118)
1. [Efficacy and tolerance of doxazosin in the treatment of isolated systolic hypertension in hypertensive patients over 60 years of age].
Calvo C; López E; Barrio E; Espejo J; Ruiz M; Vega A
An Med Interna; 1995 Mar; 12(3):122-6. PubMed ID: 7795118
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
3. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
Pessina AC
Clin Ter; 1995 Jan; 146(1):3-12. PubMed ID: 7705011
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
5. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
Ceral J; Solar M
Blood Press; 2009; 18(1-2):74-7. PubMed ID: 19353415
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the efficacy and tolerance of doxazosin vs. enalapril inaged patients with light to moderate arterial hypertension].
Puddu P; Gallucci M; Curnis A; Pupita F; Ansuini R; Malacco E
Clin Ter; 1995 Dec; 146(12):801-10. PubMed ID: 8681500
[TBL] [Abstract][Full Text] [Related]
7. [Reducing blood pressure and modification of coronary risk factors by therapy with doxazosin].
Hitzenberger G; Ganzinger U
Wien Klin Wochenschr; 1993; 105(13):371-6. PubMed ID: 8351927
[TBL] [Abstract][Full Text] [Related]
8. [Doxazosin (alpha 1-adrenoreceptor antagonist) used in primary hypertension and it's beneficial effect on lipid metabolism].
Sznajderman M; Chotkowska E; Peczkowska M; Sawicki M; Janaszek-Sitkowska H; Wiernikowska-Wegorek I; Galewicz A; Cybulska I
Kardiol Pol; 1993 Feb; 38(2):107-11. PubMed ID: 8230980
[TBL] [Abstract][Full Text] [Related]
9. Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study.
de Alvaro F; Hernández-Presa MA;
J Cardiovasc Pharmacol; 2006 Feb; 47(2):271-6. PubMed ID: 16495766
[TBL] [Abstract][Full Text] [Related]
10. Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practice.
Chung BH; Hong SJ; Lee MS
Int J Urol; 2005 Feb; 12(2):159-65. PubMed ID: 15733110
[TBL] [Abstract][Full Text] [Related]
11. Doxazosin in hypertension: results of a general practice study in 4809 patients.
Langdon CG; Packard RS
Br J Clin Pract; 1994; 48(6):293-8. PubMed ID: 7848789
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of essential arterial hypertension with hypercholesterolemia. Effects of an alpha-adrenergic blocker and an inhibitor of the angiotensin converting enzyme].
Fernández Pinilla C; Luque Otero M; Martell Claros N; Alcázar de la Osa JM; Rodicio Díaz JL; Ruilope Urioste LM
Med Clin (Barc); 1993 Jun; 101(5):168-71. PubMed ID: 8332009
[TBL] [Abstract][Full Text] [Related]
13. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy.
Ikeda T; Gomi T; Shibuya Y; Shinozaki S; Suzuki Y; Matsuda N
Hypertens Res; 2007 Nov; 30(11):1097-105. PubMed ID: 18250559
[TBL] [Abstract][Full Text] [Related]
14. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
Kamoi K; Ikarashi T
Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073
[TBL] [Abstract][Full Text] [Related]
15. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
Calvo C; Gil-Extremera B; Gomez-Fernández P; Masramon X; Pueyo C; Armada B
Int J Cardiol; 2005 May; 101(1):97-104. PubMed ID: 15860390
[TBL] [Abstract][Full Text] [Related]
16. An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study.
Kario K; Matsui Y; Shibasaki S; Eguchi K; Ishikawa J; Hoshide S; Ishikawa S; Kabutoya T; Schwartz JE; Pickering TG; Shimada K;
J Hypertens; 2008 Jun; 26(6):1257-65. PubMed ID: 18475166
[TBL] [Abstract][Full Text] [Related]
17. [Doxazosin for the treatment of arterial hypertension].
Mozzato MG; Semplicini A; Serena L; Valle R; Casolino P; Buzzaccarini F; Rubino N; Giusto M; Pessina AC
Cardiologia; 1990 Nov; 35(11):931-6. PubMed ID: 2151571
[TBL] [Abstract][Full Text] [Related]
18. [Effects of monotherapy with an alpha1-adrenoblocker doxazosin and its combination with beta1-adrenoblocker atenolol on hemodynamics, reversible myocardial ischemia in postmyocardial infarction patients with arterial hypertension].
Tepliakov AT; Gavrilova NV; Garganeeva AA
Klin Med (Mosk); 2003; 81(11):17-21. PubMed ID: 14689703
[TBL] [Abstract][Full Text] [Related]
19. [Antihypertensive therapy with doxazosin in patients with non-insulin-dependent diabetes mellitus].
Lazebnik LB; Melichenko SB; Serebrov AN
Ter Arkh; 1998; 70(2):50-4. PubMed ID: 9551574
[TBL] [Abstract][Full Text] [Related]
20. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
Yasuda G; Hasegawa K; Kuji T; Ogawa N; Shimura G; Umemura S; Tochikubo O
Diabet Med; 2005 Oct; 22(10):1394-400. PubMed ID: 16176202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
